FundingWatcher
Home / Startups / By venture fund / Versant Ventures portfolio companies

Versant Ventures portfolio companies

Updated 16 Nov 2026

https://www.versantventures.com/

Versant Ventures portfolio companies
One-time CSV
  • 21 funded companies, 20 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-investor-versant-ventures.csv21 rows × 18 columns
CompanyCityLast roundAmountDate
Firefly BioSan FranciscoSeries A$94.0M2024-02-15
Gate BioscienceBrisbaneSeries B$65.0M2025-11-13
Tentarix BiotherapeuticsSan DiegoSeries B$35.0M2023-09-06
Santa Ana BioAlamedaSeries B$125.0M2024-06-13
ViaLaseCorona Del MarSeries C$40.0M2024-04-01
Borealis BiosciencesVancouverSeries A$30.0M2024-12-19
Kate TherapeuticsSan DiegoSeries B$21.8M2024-08-07
T-knifeBerlinSeries B$110.0M2021-08-02

8 rows of the CSV in 5 of its 18 columns.

21
Startups
$1.5B
Total raised
0
Funded in the last 12 months
0
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

10 of 21
10 rows
Company What they do Sector Location Last round Amount Date Total raised Investors Employees Founded
Gate Bioscience Gate Bioscience is a biotechnology company developing small molecule treatments for hard-to-treat diseases. Biotech Brisbane, United States Series B $65.0M 2025-11-13 $125.0M Andreessen Horowitz, Google Ventures, ARCH Venture Partners +1 11 to 50 2021
Borealis Biosciences Borealis Biosciences develops RNA medicines. Biotech Vancouver, Canada Series A $30.0M 2024-12-19 $180.0M Versant Ventures, Westlake Village BioPartners 11 to 50 2024
Santa Ana Bio Santa Ana Bio develops precision immunology therapies for autoimmune and inflammatory diseases. Biotech Alameda, United States Series B $125.0M 2024-06-13 $176.0M Andreessen Horowitz, Google Ventures, TPG +2 11 to 50 2022
Tentarix Biotherapeutics Tentarix Biotherapeutics creates protein therapeutics with combined bioactivities using synthetic biology. Biotech San Diego, United States Series B $35.0M 2023-09-06 $93.0M Versant Ventures, Samsara BioCapital, Amplitude Venture Capital 11 to 50 2020
Vector BioPharma Vector BioPharma develops gene precision delivery technology to improve biologics. Biotech Basel, Switzerland Series A $30.0M 2022-08-10 $30.0M Versant Ventures 11 to 50 2021
Cimeio Therapeutics Cimeio Therapeutics develops curative treatments for genetic diseases, blood cancers, and severe autoimmune disorders. Biotech Basel, Switzerland Series A $50.0M 2022-04-13 $50.0M Versant Ventures 11 to 50 2020
Therachon Therachon is a global biotechnology company developing medicines for rare genetic diseases. Biotech Basel, Switzerland Series B $60.0M 2018-08-09 $100.0M Bpifrance, New Enterprise Associates, OrbiMed +2 1 to 10 2014
PIQUR Therapeutics PIQUR Therapeutics is a Swiss pharmaceutical company developing anti-cancer drugs. Biotech Basel, Switzerland Series A $30.9M 2017-09-01 $86.9M Venture Kick, Versant Ventures 11 to 50 2011
Synosia Therapeutics Synosia Therapeutics develops and commercializes products for unmet needs in psychiatry and neurology. Biotech Basel, Switzerland Series C $30.0M 2010-10-12 $94.0M Novo Holdings, Versant Ventures, 5AM Ventures +2 1 to 10 2006
Okairos Okairos develops genetic T-cell vaccines, including candidates targeting hepatitis C virus. Biotech Basel, Switzerland Series B $20.5M 2010-09-14 $30.1M EQT Life Sciences, Versant Ventures, Novartis Venture Fund +2 1 to 10 2007

Table 1. Versant Ventures portfolio companies: the 10 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 21.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Novartis Venture Fund Corporate venture arm Basel, Switzerland 3 14%
2 OrbiMed Private equity firm New York, United States 3 14%
3 MPM Capital Private equity firm Boston, United States 2 10%
4 Google Ventures Corporate venture arm San Francisco, United States 2 10%
5 Andreessen Horowitz Venture capital firm Menlo Park, United States 2 10%
6 Arboretum Ventures Venture capital firm Ann Arbor, United States 2 10%
7 Westlake Village BioPartners Startup incubator Westlake Village, United States 2 10%
8 EQT Life Sciences Private equity firm Amsterdam, The Netherlands 2 10%
9 Novo Holdings Corporate venture arm Hellerup, Denmark 2 10%
10 Alloy Ventures Venture capital firm Palo Alto, United States 2 10%
11 3i Group Private equity firm London, United Kingdom 2 10%
12 Decheng Capital Venture capital firm Menlo Park, United States 1 5%
13 ARCH Venture Partners Venture capital firm Chicago, United States 1 5%
14 Samsara BioCapital Private equity firm Palo Alto, United States 1 5%
15 Amplitude Venture Capital Venture capital firm Montréal, Canada 1 5%

Table 2. Versant Ventures portfolio companies: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Biotech 17 81% $1.3B
Health care 17 81% $1.3B
Software 2 10% $121.4M
Hardware 1 5% $39.0M

Table 3. Versant Ventures portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series A 6 29% $30.9M
Series B 8 38% $60.0M
Series C 5 24% $25.0M
Series D+ 2 10% $4.4M

Table 4. Versant Ventures portfolio companies by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Countries

CountriesCompaniesShare
United States 12 57%
Switzerland 6 29%
Canada 1 5%
Germany 1 5%
United Kingdom 1 5%

Table 5. Versant Ventures portfolio companies by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
Basel 6 29%
San Diego 2 10%
Menlo Park 2 10%
San Francisco 1 5%
Brisbane 1 5%
Alameda 1 5%
Corona Del Mar 1 5%
Vancouver 1 5%
Berlin 1 5%
Falmer 1 5%
Vernon Hills 1 5%
San Jose 1 5%

Table 6. Versant Ventures portfolio companies by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2025 1 5% $65.0M
2024 6 29% $343.8M
2023 1 5% $35.0M
2022 2 10% $80.0M
2021 1 5% $110.0M
2018 1 5% $60.0M

Table 7. Versant Ventures portfolio companies by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 1 5%
2020 to 2022 7 33%
2015 to 2019 2 10%
2010 to 2014 3 14%
Before 2010 8 38%

Table 8. Versant Ventures portfolio companies by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 5 25%
11 to 50 12 60%
51 to 100 2 10%
501 to 1,000 1 5%

Table 9. Versant Ventures portfolio companies by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many Versant Ventures portfolio companies are on the list?
21, in the file dated 16 November 2026.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 21 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Versant Ventures portfolio companies: 21 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Portfolio companies by country

Portfolio companies by city

Other venture fund portfolios

Cite: FundingWatcher, 21 startups, 16 November 2026. https://fundingwatcher.com/startups/investor/versant-ventures/